SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a business update and reported ...

Tovecimig (DLL4 x VEGF-A bispecific antibody) met the primary endpoint in the ongoing randomized Phase 2/3 Study in patients with biliary tract cancer (BTC). Achieved a 17.1% overall response rate ...

Researchers from the Karolinska Institutet in Sweden have found a potential new treatment for non-alcoholic fatty liver ...

Dr. Shirley D'Sa discusses the importance of catching peripheral neuropathy in patients with Waldenstrom macroglobulinemia ...

Some people may be more vulnerable to infections and illnesses than others and several factors can be to blame Here’s what a ...

A cocktail of 3 agents provides broad protection against 13 deadly snakes, but a ‘universal antivenom’ isn’t on the horizon ...

Scientists hope to make a universal antivenom from the extraordinary blood of a man exposed to snake venom for decades.

Scientists identified antibodies that neutralized the poison in whole or in part from the bites of cobras, mambas and other ...

Over the course of 18 years, a truck mechanic from Wisconsin injected himself with snake venom hundreds of times. His actions ...

Disproven alternative therapies for treating cognitive symptoms in Alzheimer's disease include omega-3 fatty acids, huperzine ...

Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune ...

SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (Nasdaq: IBIO) ("iBio" or the "Company"), an AI-driven innovator of precision antibody therapies, announces today announced that it has entered ...